DE69807104T2 - Formulierungen mit gesteuerter freisetzung - Google Patents

Formulierungen mit gesteuerter freisetzung

Info

Publication number
DE69807104T2
DE69807104T2 DE69807104T DE69807104T DE69807104T2 DE 69807104 T2 DE69807104 T2 DE 69807104T2 DE 69807104 T DE69807104 T DE 69807104T DE 69807104 T DE69807104 T DE 69807104T DE 69807104 T2 DE69807104 T2 DE 69807104T2
Authority
DE
Germany
Prior art keywords
film
composition
forming
controlled release
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69807104T
Other languages
English (en)
Other versions
DE69807104D1 (de
Inventor
Michael Newton
Fung Siew
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alizyme Therapeutics Ltd
Original Assignee
BTG International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BTG International Ltd filed Critical BTG International Ltd
Application granted granted Critical
Publication of DE69807104D1 publication Critical patent/DE69807104D1/de
Publication of DE69807104T2 publication Critical patent/DE69807104T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
DE69807104T 1997-10-23 1998-10-23 Formulierungen mit gesteuerter freisetzung Expired - Lifetime DE69807104T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9722426.5A GB9722426D0 (en) 1997-10-23 1997-10-23 Controlled release formulations
PCT/GB1998/003178 WO1999021536A1 (en) 1997-10-23 1998-10-23 Controlled release formulations

Publications (2)

Publication Number Publication Date
DE69807104D1 DE69807104D1 (de) 2002-09-12
DE69807104T2 true DE69807104T2 (de) 2002-12-05

Family

ID=10820995

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69807104T Expired - Lifetime DE69807104T2 (de) 1997-10-23 1998-10-23 Formulierungen mit gesteuerter freisetzung

Country Status (10)

Country Link
US (1) US6534549B1 (de)
EP (1) EP1024795B1 (de)
JP (2) JP2001520986A (de)
AT (1) ATE221773T1 (de)
CA (1) CA2302585C (de)
DE (1) DE69807104T2 (de)
DK (1) DK1024795T3 (de)
ES (1) ES2178268T3 (de)
GB (1) GB9722426D0 (de)
WO (1) WO1999021536A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6929884B2 (en) * 2001-04-19 2005-08-16 Zinc Matrix Power, Inc. Method for manufacture of films containing insoluble solids embedded in cellulose-based films
AR036797A1 (es) 2001-10-15 2004-10-06 Ferring Bv Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn
GB0203421D0 (en) * 2002-02-13 2002-04-03 Alizyme Therapeutics Ltd Composition
WO2004093883A2 (en) 2003-04-23 2004-11-04 Ferring B.V. Sachet for a pharmaceutical composition
FR2862654B1 (fr) * 2003-11-20 2006-02-10 Roquette Freres Composition amylacee filmogene
EP1547601A1 (de) 2003-12-23 2005-06-29 Ferring B.V. Beschichtungsverfahren
WO2005097061A1 (en) * 2004-04-01 2005-10-20 Procyte Corporation Encapsulated peptide copper complexes and compositions and methods related thereto
US8048919B2 (en) * 2004-06-28 2011-11-01 Archer Daniels Midland Company Use of ethyl lactate as an excipient for pharmaceutical compositions
TW200700107A (en) * 2005-03-16 2007-01-01 Procyte Corp Methods and compositions for preventing and treating aging or photodamaged skin
US20090017110A1 (en) * 2005-05-31 2009-01-15 Capricorn Pharma Inc. Modified release formulations of anti-irritability drugs
GB0607534D0 (en) * 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
CA2658915A1 (en) * 2006-07-27 2008-01-31 University Of Sunderland Coating composition comprising starch
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
CN102017232B (zh) 2008-03-27 2014-07-02 Z动力能源有限责任公司 电极隔板
GB0808537D0 (en) * 2008-05-12 2008-06-18 Archimedes Dev Ltd Compositions
FR2934467B1 (fr) * 2008-07-31 2014-08-22 Roquette Freres Forme solide pelliculee et procede de pelliculage a temperature ambiante.
ES2425762T3 (es) 2008-10-27 2013-10-17 Roquette Freres Polímero insoluble en agua: revestimientos de película a base de derivados de almidón modificado para la liberación dirigida al colon
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
US9006288B2 (en) 2009-01-12 2015-04-14 Biokier, Inc. Composition and method for treatment of diabetes
SI2376077T1 (sl) 2009-01-12 2017-09-29 Biokier Inc. Sestavek in metoda za zdravljenje diabetesa
US9314444B2 (en) 2009-01-12 2016-04-19 Biokier, Inc. Composition and method for treatment of NASH
MX2012003459A (es) 2009-09-23 2012-05-22 Biokier Inc Composicion y metodo para el tratamiento de la diabetes.
AU2010300550B2 (en) 2009-10-01 2014-10-30 Adare Pharmaceuticals, Inc. Orally administered corticosteroid compositions
SG190817A1 (en) 2010-11-15 2013-07-31 Archer Daniels Midland Co Compositions and uses thereof in converting contaminants
NO2659881T3 (de) 2012-04-30 2018-04-28
US20140271931A1 (en) * 2013-03-12 2014-09-18 Perosphere Inc. Anti-Acne Topical Films
BR122020013726B1 (pt) 2013-10-29 2022-11-01 Tillotts Pharma Ag Formulação de droga de liberação retardada
EP3662901A1 (de) 2018-12-07 2020-06-10 Tillotts Pharma AG Arzeimittelformulierung mit verzögerter freisetzung mit einer aussenschicht enthaltend ein enzymatisch abbaubares polymer, ihre zusammensetzung und ihr herstellungsverfahren
EP3662898A1 (de) 2018-12-07 2020-06-10 Tillotts Pharma AG Feste formulierung enthaltend mesalazin
EP3662900A1 (de) 2018-12-07 2020-06-10 Tillotts Pharma AG Kolonwirkstoffverabreichungsformulierung
EP3662902A1 (de) 2018-12-07 2020-06-10 Tillotts Pharma AG Formulierung mit freisetzung eines wirkstoffs im kolon
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8926639D0 (en) * 1989-11-24 1990-01-17 Agricultural & Food Res Delayed release formulations

Also Published As

Publication number Publication date
EP1024795A1 (de) 2000-08-09
CA2302585A1 (en) 1999-05-06
JP2010270335A (ja) 2010-12-02
JP2001520986A (ja) 2001-11-06
DE69807104D1 (de) 2002-09-12
US6534549B1 (en) 2003-03-18
ES2178268T3 (es) 2002-12-16
WO1999021536A1 (en) 1999-05-06
CA2302585C (en) 2007-09-25
ATE221773T1 (de) 2002-08-15
DK1024795T3 (da) 2002-12-02
GB9722426D0 (en) 1997-12-24
EP1024795B1 (de) 2002-08-07

Similar Documents

Publication Publication Date Title
ATE221773T1 (de) Formulierungen mit gesteuerter freisetzung
DE69832621D1 (de) Pharmazeutische formulierungen mit kontrollierter freigabe von wirkstoffen
DK0729357T3 (da) Mikroindkapslede 1,2-benzazoler
DE69407404D1 (de) Feste zubereitung mit hoher freisetzung, ihre herstellung und verwendung
KR930003906A (ko) 약학적 구상 제형
DE69331906D1 (de) Granulierte pharmazeutische zusammensetzung
PT1017367E (pt) Metodos para fabricar preparacoes de libertacao controlada baseadas em polimeros
NO870558D0 (no) Fremgangsmaate for fremstilling av et langsomt frigivende farmasoeytisk preparat.
ATE356614T1 (de) Veränderung der wirkstoffladung in multivesikulären liposomen
KR900002769A (ko) 장시간 작용하는 나트륨 디클로페낙의 제제
ATE229327T1 (de) Verwendung von redispergierbaren polymerpulvern oder polymergranulaten zum überziehen von pharmazeutischen oder agrochemischen darreichungsformen
ATE273002T1 (de) Feste lösung eines fungizids mit erhöhter bioverfügbarkeit
EP0297866A3 (de) Arzneimittel
JPS5312978A (en) Isolation of low-molecular weight polymers
CA2020590A1 (en) Solid pharmaceutical composition containing a core and an outer layer
BG60697B2 (en) Medicamentous form having continous release based on ethodolacquer
CA2258679A1 (en) Solid solution of an antifungal agent with enhanced bioavailability

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ALIZYME THERAPEUTICS LTD., GREAT ABINGTON, CAMBRID